Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases-Reference-Cited by-同舟云学术

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

Published:2019-02-07 Issue:6 Volume:20 Page:635-645
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Pérez-Lloret Santiago¹²^ORCID,Quarracino Cecilia¹,Otero-Losada Matilde¹,Rascol Olivier³

Affiliation:

1. Instituto de Investigaciones Cardiológicas, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina

2. Department of Physiology, School of Medicine, University of Buenos Aires (UBA), Buenos Aires, Argentina

3. Services de Pharmacologie Clinique et Neurosciences, Centre d’Investigation Clinique CIC 1436, NS-Park/FCRIN Network, NeuroToul COEN Center, Université de Toulouse UPS, CHU de Toulouse, INSERM, Toulouse, France

Funder

self-funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1574746

Reference86 articles.

1. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

2. Neurogenic Orthostatic Hypotension

3. The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension

4. Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)

5. Orthostatic hypotension in Parkinson's disease: association with cognitive decline?

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple system atrophy;Practical Neurology;2023-03-16

2. Multiple system atrophy;PRACT NEUROL;2023

3. Ataxias: Hereditary, Acquired, and Reversible Etiologies;Seminars in Neurology;2023-02

4. Improving the Cβ stereoselectivity of L-threonine aldolase for the preparation of L-threo-3,4-dihydroxyphenylserine, a powerful anti-Parkinson's disease drug;Biochemical Engineering Journal;2023-02

5. Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies;Expert Opinion on Investigational Drugs;2022-09-11